Vista Gel Hypromellose Eye Drops Recalled Nationwide Due to Sterility Concerns
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Wizcure Pharmaa Private Limited has issued a voluntary recall for 17,280 cartons of Vista Gel Hypromellose eye drops due to a lack of assurance of sterility.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Wizcure Pharmaa Private Limited has initiated a voluntary recall of Vista Gel Hypromellose USP 0.3% w/v eye drops. The recall was triggered due to a lack of assurance of sterility, as the products were found to have been manufactured in a manner that does not conform to current good manufacturing practices (CGMP).
Which Products Are Affected
The recall involves the following product distributed nationwide in the United States:
- Product Name: Vista Gel Hypromellose USP 0.3% w/v, Eye Drops Dry Eye Relief Lubricating Gel
- Size: 10 ml (1/3 fl. oz)
- NDC Number: 77790-002-10
- Brand Name: VISTA HYPROMELLOSE DRY EYE RELIEF
- Quantity: 17,280 cartons
- Lot Information: All lots are included in this recall.
- Manufacturer: Wizcure Pharmaa Private Limited (Bhiwadi, India)
- Distributor: hi-health (Scottsdale, AZ)
- Recall Number: D-0347-2026
What You Should Do
Consumers who possess the affected eye drops should stop using the product immediately. The recalling firm initiated notification via letter on December 31, 2025. Consumers seeking information regarding returns or potential health concerns should contact their healthcare provider and the distributor, hi-health, located at 15207 N. 75th Street, Suite #104, Scottsdale, AZ, 85260.
Why This Matters
Using ophthalmic products that lack assurance of sterility poses a significant risk to consumers, as contaminated eye drops can lead to serious eye infections and potential vision impairment. This Class II recall indicates that the product may cause temporary or medically reversible adverse health consequences.
Source
Information provided by the FDA (Event ID: 98253).
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.